| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $132.16K | $119.86K | $116.71K | $120.35K | $141.87K |
| R&D | – | – | – | – | – |
| SG&A | $132.16K | $126.98K | $116.71K | $120.35K | $141.87K |
| Operating Income | -$132.16K | -$119.95K | -$116.71K | -$120.35K | -$141.87K |
| Interest Expense | $94.03K | $84.92K | $75.03K | $64.00K | $53.00K |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$226.19K | -$204.87K | -$191.74K | -$184.64K | -$194.85K |
| EPS (basic) | 0.0000 | 0.0000 | – | – | – |
| EPS (diluted) | 0.0000 | 0.0000 | – | – | – |
| Shares (diluted) | $441.48M | $441.48M | $441.48M | $441.48M | $441.48M |